Pancreaticoduodenectomy: A 20-year experience in 516 patients

HYPOTHESIS Pancreaticoduodenectomy (PD) is a safe procedure for a variety of periampullary conditions. DESIGN Retrospective review of a prospectively collected database. SETTING Academic tertiary care hospital. PATIENTS A total of 516 consecutive patients who underwent PD. MAIN OUTCOME MEASURES Patient outcomes and survival factors. RESULTS Pathological examination demonstrated 57% periampullary cancers, 22% chronic pancreatitis, 12% cystic neoplasms, 4% islet cell neoplasms, and 5% other. Fifty-one percent of patients underwent pylorus preservation. Median operating time was 5 hours; blood loss, 1300 mL; and transfusion requirement, 1.5 U. Postoperative complications occurred in 43% of patients, including cardiopulmonary events (15%), fistula (9%), delayed gastric emptying (7%), and sepsis (6%). Additional surgery was required in 3% of patients, most commonly because of bleeding. Perioperative mortality was 3.9% overall but only 1.8% in patients with chronic pancreatitis; 25% of patients who died had preoperative complications associated with their periampullary condition. Three-year survival was 15% after resection for pancreatic cancer, 42% for duodenal cancer, 53% for ampullary cancer, and 62% for bile duct cancer. Univariate predictors of long-term survival in patients with periampullary adenocarcinoma included elevated glucose levels, liver function test results, abnormal tumor markers, blood loss, transfusion requirement, type of operation, and pathologic findings (periampullary adenocarcinoma type, differentiation, and margin and node status). Multivariate predictors were serum total bilirubin level, blood loss, operation type, diagnosis, and lymph node status. CONCLUSIONS Pancreaticoduodenectomy continues to be associated with considerable morbidity. With careful patient selection, PD can be performed safely. Long-term survival in patients with periampullary adenocarcinoma can be predicted by preoperative laboratory values, intraoperative factors, and pathologic findings.

[1]  S. Sherman,et al.  Mucin Secreting Cystic Lesions of the Pancreas: Treatment by Enucleation , 2004, The American surgeon.

[2]  S. Creech,et al.  Zero mortality after 152 consecutive pancreaticoduodenectomies with pancreaticogastrostomy. , 2003, Journal of the American College of Surgeons.

[3]  J. Howard.  Development and Progress in Resective Surgery for Pancreatic Cancer , 1999, World Journal of Surgery.

[4]  P. Lin,et al.  Prospective randomized comparison between pylorus‐preserving and standard pancreaticoduodenectomy , 1999, The British journal of surgery.

[5]  M. Talamini,et al.  Cystadenomas of the pancreas: is enucleation an adequate operation? , 1998, Annals of surgery.

[6]  M. Talamini,et al.  Six hundred fifty consecutive pancreaticoduodenectomies in the 1990s: pathology, complications, and outcomes. , 1997, Annals of surgery.

[7]  D. Rattner,et al.  Standards for pancreatic resection in the 1990s. , 1995, Archives of surgery.

[8]  J. Tielsch,et al.  The Effects of Regionalization on Cost and Outcome for One General High‐Risk Surgical Procedure , 1995, Annals of surgery.

[9]  M. Lieberman,et al.  Relation of Perioperative Deaths to Hospital Volume Among Patients Undergoing Pancreatic Resection for Malignancy , 1993, Annals of surgery.

[10]  K. Lillemoe,et al.  One hundred and forty-five consecutive pancreaticoduodenectomies without mortality. , 1993, Annals of surgery.

[11]  H. Saeger,et al.  Survival After Pancreatoduodenectomy: 118 Consecutive Resections Without an Operative Mortality , 1990, Annals of surgery.

[12]  Birgir Gudjonsson,et al.  Cancer of the pancreas: 50 years of surgery , 1987, Cancer.

[13]  T. Shapiro.  Adenocarcinoma of the Pancreas: A Statistical Analysis of Biliary Bypass vs Whipple Resection in Good Risk Patients , 1975, Annals of surgery.

[14]  R. Gilsdorf,et al.  Factors influencing morbidity and mortality in pancreaticoduodenectomy. , 1973, Annals of surgery.

[15]  Blalock Jb,et al.  Pancreatoduodenectomy: a retrospective review 1949 to 1969. , 1972 .

[16]  G. Crile.  The advantages of bypass operations over radical pancreatoduodenectomy in the treatment of pancreatic carcinoma. , 1970, Surgery, gynecology & obstetrics.

[17]  J. Howard.  Pancreatico‐Duodenectomy: Forty‐One Consecutive Whipple Resections without an Operative Mortality , 1968, Annals of surgery.

[18]  J. J. Monge,et al.  RADICAL PANCREATODUODENECTOMY: A 22-YEAR EXPERIENCE WITH THE COMPLICATIONS, MORTALITY RATE, AND SURVIVAL RATE. , 1964, Annals of surgery.

[19]  A O Whipple,et al.  TREATMENT OF CARCINOMA OF THE AMPULLA OF VATER. , 1935, Annals of surgery.

[20]  W. Halsted.  Contributions to the Surgery of the Bile Passages, Especially of the Common Bile-Duct , 1899 .

[21]  M. Büchler,et al.  Duodenum-preserving resection of the head of the pancreas in chronic pancreatitis with inflammatory mass in the head , 2005, World Journal of Surgery.

[22]  K. Campbell,et al.  Standard vs. radical pancreaticoduodenectomy for periampullary adenocarcinoma: A prospective, randomized trial evaluating quality of life in pancreaticoduodenectomy survivors , 2003, Journal of Gastrointestinal Surgery.

[23]  J. Blalock,et al.  Pancreatoduodenectomy: a retrospective review 1949 to 1969. , 1972, The American surgeon.